32.7 C
Vientiane
Wednesday, August 20, 2025
spot_img
Home Blog Page 662

INLIF LIMITED Reports Fiscal Year 2024 Financial Results

QUANZHOU, China, April 30, 2025 /PRNewswire/ — INLIF LIMITED (Nasdaq: INLF) (the “Company” or “INLIF”), a company engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms, today announced its financial results for the year ended December 31, 2024.

Mr. Rongjun Xu, the chief executive officer of INLIF, remarked, “We are thrilled to report the performance for fiscal year 2024, with growth recorded across revenue, gross profit, and net income. This success was fueled by sustained demand from existing clients and new customers acquired through our strategic marketing initiatives. Our strategic expansion also played a pivotal role in driving sales growth and penetrating new sectors and emerging markets. These combined efforts resulted in a 25.26% year-over-year increase in revenue. As sales increased, our gross margin declined slightly to 28.83%, which contributed to a 9.49% increase in gross profit, highlighting our profitability and effective cost control measures.

“In preparation for our Nasdaq listing and to unlock greater opportunities in new markets, we launched proactive marketing campaigns and offered attractive incentive commissions to enhance brand recognition and order acquisition. These efforts included participation in exhibitions across China and exploration of overseas markets, particularly in Southeast Asia and India. Meanwhile, we have supported our revenue growth with only a moderate increase in operational costs. We continued to invest in research and development, and we plan to accelerate the acquisition of talents, patents, and technologies to meet the evolving and diversifying needs of the market.

“Thanks to the outstanding efforts of our team and the strong execution of our strategic initiatives, net income rose by 18.78% during our first financial report post-listing. Looking ahead, we anticipate opportunities for continued growth and development, supported by the enhanced visibility and access to capital provided by our Nasdaq listing. In addition, the rise of emerging technology innovations and the increasing adoption of automation infrastructure are expected to significantly accelerate growth in the manipulator arms industry. We are confident that our proactive and pragmatic business strategies will place us on a sustainable and thriving path, delivering long-term value to the Company and our shareholders.”

Fiscal Year 2024 Financial Highlights 

  • Net revenue was $15.80 million for fiscal year 2024, representing an increase of 25.26% from $12.61 million for fiscal year 2023.
  • Gross profit was $4.55 million for fiscal year 2024, representing an increase of 9.49% from $4.16 million for fiscal year 2023.
  • Gross profit margin was 28.83% for fiscal year 2024, compared to 32.98% for fiscal year 2023.
  • Net income was $1.61 million for fiscal year 2024, representing an increase of 18.78% from $1.35 million for fiscal year 2023.
  • Basic and diluted earnings per share were $0.13 for fiscal year 2024, compared to $0.11 for fiscal year 2023.

Fiscal Year 2024 Financial Results 

Net Revenue

Net revenue was $15.80 million for fiscal year 2024, representing an increase of 25.26% from $12.61 million for fiscal year 2023. The increase was primarily attributable to (i) an increase in sales of manipulator arms, including installation and warranty services, by approximately $0.51 million; (ii) an increase in sales of manipulator arms accessories by approximately $0.44 million; (iii) an increase in sales of raw materials and scraps by approximately $2.27 million; and (iv) a decrease in sales of installation services by approximately $0.04 million.

  • Sales of manipulator arms and installation and warranty services were $10.33 million for fiscal year 2024, representing an increase of 5.23% from $9.82 million for fiscal year 2023.
  • Sales of accessories were $1.44 million for fiscal year 2024, representing an increase of 44.08% from $1.00 million for fiscal year 2023.
  • Sales of raw materials and scraps were $3.93 million for fiscal year 2024, representing an increase of 136.61% from $1.66 million for fiscal year 2023.
  • Sales of installation services were $95,442 for fiscal year 2024, representing a decrease of 29.14% from $134,697 for fiscal year 2023.

Cost of Revenue

Cost of revenue was $11.24 million for fiscal year 2024, representing an increase of 33.03% from $8.45 million for fiscal year 2023. The increase was primarily attributable to the Company’s business growth and an increase in sales resulting in an increase in costs accordingly.

Gross Profit and Gross Profit Margin

Gross profit was $4.55 million for fiscal year 2024, representing an increase of 9.49% from $4.16 million for fiscal year 2023. The increase mainly due to (i) an increase in gross profit from sales of manipulator arms, including installation and warranty services, by approximately $0.47 million; (ii) a decrease in gross profit from sales of manipulator arms accessories by approximately $0.11 million; (iii) an increase in gross profit from sales of raw materials and scraps by approximately $0.06 million; and (iv) a decrease in gross profit from sales of installation services by approximately $0.03 million.

Gross profit margin was 28.83% for fiscal year 2024, compared to 32.98% for fiscal year 2023.

Operating Expenses

Operating expenses were $3.27 million for fiscal year 2024, representing an increase of 17.74% from $2.77 million for fiscal year 2023.

  • Selling expenses were $0.94 million for fiscal year 2024, representing an increase of 36.46% from $0.69 million for fiscal year 2023. The increase was mainly due to (i) an increase in exhibition expenses by approximately $0.12 million, resulting from participation in an additional four exhibitions across four cities in China in 2024; (ii) an increase in salary by approximately $0.12 million, as the growth in revenue has led to higher commissions for sales personnel, alongside the addition of three sales representatives in 2024 compared to 2023; and (iii) an increase in transportation fees by approximately $0.19 million, due to increase of sales to customers from other provinces, such as Guangdong, Zhejiang, and Jiangsu, resulting in a rise in related transportation costs.
  • General and administrative expenses were $0.76 million for fiscal year 2024, representing an increase of 5.58% from $0.72 million for fiscal year 2023. The increase was mainly due to an increase in consulting fees for external public relations and internal control.
  • Research and development expenses were $1.56 million for fiscal year 2024, representing an increase of 14.76% from $1.36 million for the same period of last year. The increase was primarily attributable to increased investment in research and corresponding material consumption to enhance the quality and performance of manipulator arms.

Net Income

Net income was $1.61 million for fiscal year 2024, representing an increase of 18.78% from $1.35 million for fiscal year 2023.

Basic and Diluted Earnings per Share

Basic and diluted earnings per share were $0.13 for fiscal year 2024, compared to $0.11 for fiscal year 2023.

Financial Condition

As of December 31, 2024, the Company had cash and cash equivalents of $2.47 million, compared to $0.60 million as of December 31, 2023.

Net cash provided by operating activities was $1.58 million for fiscal year 2024, compared to $0.40 million for fiscal year 2023.

Net cash provided by investing activities was $0.32 million for fiscal year 2024, compared to net cash used in investing activities of $0.22 million for fiscal year 2023.

Net cash provided by financing activities was $0.22 million for fiscal year 2024, compared to $0.46 million for fiscal year 2023.

Recent Development

On January 3, 2025, the Company completed its initial public offering of 2,000,000 ordinary shares at a public offering price of US$4.00 per share. The Company’s ordinary shares began trading on the Nasdaq Capital Market on January 2, 2025, under the ticker symbol “INLF.”

About INLIF LIMITED

Through its operating entity in the People’s Republic of China, Ewatt Robot Equipment Co. Ltd., established in September 2016, INLIF is engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms. It is also a provider of installation services and warranty services for manipulator arms, and accessories and raw materials for manipulator arms. The Company produces an extensive portfolio of injection molding machine-dedicated manipulator arms, including transverse single and double-axis manipulator arms, transverse and longitudinal multi-axis manipulator arms, and large bullhead multi-axis manipulator arms, all developed by itself. For more information, please visit the Company’s website: https://ir.yiwate88.com/.

Forward-Looking Statements

Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can find many (but not all) of these statements by the use of words such as “approximates,” “believes,” “hopes,” “expects,” “anticipates,” “estimates,” “projects,” “intends,” “plans,” “will,” “would,” “should,” “could,” “may” or other similar expressions. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. These statements are subject to uncertainties and risks, including, but not limited to, the uncertainties related to market conditions, and other factors discussed in the “Risk Factors” section of the registration statement filed with the U.S. Securities and Exchange Commission (the “SEC“). Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statement and other filings with the SEC. Additional factors are discussed in the Company’s filings with the SEC, which are available for review at www.sec.gov.

For investor and media inquiries, please contact:

INLIF LIMITED
Investor Relations Department
Email: ir@yiwate88.com

Ascent Investor Relations LLC

Tina Xiao
Phone: +1-646-932-7242
Email: investors@ascent-ir.com 

 

INLIF LIMITED

CONSOLIDATED BALANCE SHEETS

(Expressed in U.S. Dollars, except for the number of shares)

As of 
December 31, 
2024

As of 
December 31, 
2023

ASSETS

CURRENT ASSETS:

Cash and cash equivalents

$

2,467,638

$

598,933

Accounts receivable, net

3,840,120

3,789,214

Inventories

5,300,458

4,493,042

Deferred offering costs, current

1,482,558

Prepayments and other current assets

159,570

142,095

Amounts due from related parties

1,030

352,118

TOTAL CURRENT ASSETS

$

13,251,374

$

9,375,402

NON-CURRENT ASSETS:

Property, plant, and equipment, net

$

3,037,312

$

3,397,167

Land-use rights, net

2,130,164

2,237,684

Intangible assets, net

43,773

50,297

Deferred offering costs, non-current

960,241

Deferred tax assets

5,169

452

TOTAL NON-CURRENT ASSETS

$

5,216,418

$

6,645,841

TOTAL ASSETS

$

18,467,792

$

16,021,243

LIABILITIES

CURRENT LIABILITIES:

Accounts payable

$

3,132,613

$

2,546,418

Bank loans

4,630,581

3,662,023

Contract liabilities

1,712

65,073

Accrued expenses and other payables

222,247

259,648

Income taxes payable

27,337

12,058

Amounts due to related parties

186,768

513,018

TOTAL CURRENT LIABILITIES

$

8,201,258

$

7,058,238

TOTAL LIABILITIES

$

8,201,258

$

7,058,238

COMMITMENTS AND CONTINGENCIES (NOTE 19)

SHAREHOLDERS’ EQUITY

Ordinary shares ($0.0001 par value, 500,000,000 shares authorized, 12,500,000
     shares issued and outstanding as of December 31, 2024 and 2023)*

$

1,250

$

1,250

Additional paid-in capital

7,037,503

7,037,503

Statutory reserve

361,083

200,229

Retained earnings

3,201,818

1,756,183

Accumulated other comprehensive loss

(335,120)

(32,160)

TOTAL SHAREHOLDERS’ EQUITY

$

10,266,534

$

8,963,005

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

$

18,467,792

$

16,021,243

*     The share amounts are presented on a retrospective basis.

 

INLIF LIMITED

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME

(Expressed in U.S. Dollars, except for the number of shares)

Years ended December 31,

2024

2023

2022

Revenues

15,796,983

12,610,873

6,652,308

Cost of revenues

(11,242,817)

(8,451,336)

(4,358,426)

Gross profit

4,554,166

4,159,537

2,293,882

Operating expenses:

Selling expenses

(938,941)

(688,064)

(396,421)

General and administrative expenses

(764,530)

(724,147)

(742,620)

Research and development expenses

(1,563,059)

(1,362,058)

(504,711)

Total operating expenses

(3,266,530)

(2,774,269)

(1,643,752)

Operating income

1,287,636

1,385,268

650,130

Other income (expenses):

Interest income

3,274

6,884

2,625

Interest expenses

(196,304)

(146,386)

(82,672)

Other income, net

531,198

110,159

15,010

Other expense, net

(8,370)

(17,410)

(44,274)

Exchange gain (loss)

3,893

25,344

(3,687)

Total other income (expenses), net

333,691

(21,409)

(112,998)

Income before income tax

1,621,327

1,363,859

537,132

Income tax (expenses) benefits

(14,838)

(11,348)

423

Net income

1,606,489

1,352,511

537,555

Comprehensive income

Net income

1,606,489

1,352,511

537,555

Foreign currency translation adjustments, net of tax

(302,960)

(227,278)

187,942

Comprehensive income

1,303,529

1,125,233

725,497

Earnings per share, basic and diluted

0.13

0.11

0.04

Weighted average number of shares*

12,500,000

12,500,000

12,500,000

*     The share amounts are presented on a retrospective basis.

 

INLIF LIMITED

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Expressed in U.S. Dollars, except for the number of shares)

For the years ended

December 31,

2024

2023

2022

Cash flows from operating activities:

Net income

1,606,489

1,352,511

537,555

Adjustments to reconcile net income (loss) to net cash used in operating 
     activities:

Depreciation and amortization

347,977

367,029

388,233

Allowance for (reversal of) credit losses

(154)

(19,930)

15,975

Loss on disposal of property, plant, and equipment

5,432

Deferred tax assets

(423)

Changes in operating assets and liabilities:

Accounts receivable

(50,752)

(1,552,991)

(716,876)

Intangible assets

(53,086)

Inventories

(807,416)

(2,025,725)

1,093,218

Prepayments and other current assets

(17,474)

94,160

170,093

Accounts payable, trade

586,195

2,057,775

(103,240)

Contract liabilities

(63,361)

65,073

(137,699)

Other payables and accrued liabilities

(37,401)

98,485

(7,507)

Tax payable

15,279

11,505

(301)

Net cash provided by operating activities

1,579,382

400,238

1,239,028

Cash flows from investing activities:

Purchase of property, plant, and equipment

(25,759)

(219,121)

(18,165)

Disposal of property, plant, and equipment

989

Amount loan to related parties

(1,025)

Proceeds from repayment by related parties

347,428

Net cash provided by (used in) investing activities

320,644

(218,132)

(18,165)

Cash flows from financing activities:

Capital Contributions

6,760,538

Proceeds from short-term loans

7,143,130

3,671,841

2,526,378

Repayment of short-term loans

(6,059,153)

(2,400,819)

(1,486,105)

Deferred offering costs

(522,318)

(919,207)

(42,060)

Amount financed from related parties

181,116

977,418

515,678

Amount repaid to related parties

(518,379)

(865,770)

(9,993,772)

Net cash provided by (used in) financing activities

224,396

463,463

(1,719,343)

Effect of exchange rate changes

(255,717)

(131,597)

397,892

Net increase (decrease) in cash

1,868,705

513,972

(100,588)

Cash and cash equivalents at beginning of the year

598,933

84,961

185,549

Cash and cash equivalents at end of the year

2,467,638

598,933

84,961

Supplemental disclosures of cash flows information:

Cash paid for income taxes

1,707

475

303

Cash paid for interest expense

191,859

143,727

82,672

 

UNLIMEAT Rolls Out Its Bold Korean Plant-Based Meats at Kroger

  • The innovative Korean brand introduces its plant-based Bulgogi and Pulled Pork to over 300 Kroger stores nationwide
  • With demand for Korean flavors at an all-time high, UNLIMEAT brings authentic taste and sustainability to mainstream grocery aisles 

LOS ANGELES, April 30, 2025 /PRNewswire/ — Korean cuisine is experiencing unprecedented growth across the United States. According to a September 2024 report by Circana, a leading consumer behavior analytics firm, Korean restaurant locations in the U.S. increased by 10% over the past year. In a historic milestone, Jungsik in New York City became the first Korean restaurant in the U.S. to earn three Michelin stars. In total, 16 Korean restaurants nationwide have earned at least one Michelin star — the highest number to date — reflecting the growing recognition of Korean culinary excellence. Meanwhile, Korean food-related hashtags have surpassed 15 billion views on TikTok, signaling mainstream fascination with K-cuisine across digital and cultural platforms.

Building on this cultural momentum, UNLIMEAT, an innovative Korean plant-based meat brand, is expanding its market presence with the rollout of two flagship products — Korean BBQ Bulgogi and Pulled Pork Original — to more than 300 Kroger-affiliated stores nationwide. These products will be available in divisions including Ralphs, Fred Meyer, King Soopers, and Smith’s, bringing authentic Korean flavors to the mainstream freezer aisle.

Founded in Seoul, UNLIMEAT is rooted in sustainability and culinary innovation. The brand transforms surplus grains and legumes into clean-label, flavorful meat alternatives that are 100% vegan and non-GMO. Designed for easy preparation, its products offer a convenient and delicious way to enjoy the bold, savory essence of Korean cuisine — without compromising on health or environmental impact. The company is now expanding its lineup to include a wider range of Korean-inspired ready-to-eat meals featuring its signature plant-based proteins.

UNLIMEAT Products - Korean BBQ Bulgogi, Pulled Pork Original
UNLIMEAT Products – Korean BBQ Bulgogi, Pulled Pork Original

  • Korean BBQ Bulgogi: A sweet and savory classic, this plant-based version is marinated in a soy garlic sauce, ideal for stir-fries, bowls, salads, or lettuce wraps.
  • Pulled Pork Original: Juicy and tender with a satisfying bite, this versatile protein is perfect for tacos, sliders, or Korean-fusion dishes.

While headlines often suggest a slowdown in the plant-based market, UNLIMEAT continues to grow steadily thanks to strong customer support. “We’re excited to bring the bold flavors of Korean cuisine to a broader audience through our partnership with Kroger,” said a UNLIMEAT spokesperson. “Our mission is to make the healthy appeal of Korean cuisine more accessible to American tables, while delivering a balanced complete Korean meal experience — all through the lens of sustainable, plant-based innovation.”

As the largest supermarket chain in the U.S., Kroger continues to expand its plant-based offerings to meet evolving consumer preferences. The addition of UNLIMEAT’s products provides shoppers with globally inspired choices that align with modern dietary trends and growing cultural curiosity. UNLIMEAT’s Korean BBQ Bulgogi and Pulled Pork Original will be available in Kroger-affiliated stores starting in May.

Appian Customers Unlock AI’s Full Potential by Embedding It in Business Processes

DENVER, April 30, 2025 /PRNewswire/ — Appian (Nasdaq: APPN) is giving customers the power to have AI work directly in their business processes. As the Process Company, Appian believes better processes are the key to better business outcomes. AI makes the most impact when it operates within business processes, gaining purpose, governance, and accountability.

Appian customers, including Acclaim Autism, Century Fire Protection, Hitachi, the Texas Department of Public Safety, and the University of South Florida, are seeing transformative outcomes from this process-first approach.
Appian customers, including Acclaim Autism, Century Fire Protection, Hitachi, the Texas Department of Public Safety, and the University of South Florida, are seeing transformative outcomes from this process-first approach.

Appian’s customer AI adoption has increased 7.9x year-over-year to process more items through AI-powered document extraction. Additionally, 70% of Appian Cloud customers are already using AI — from AI assistance in process modeling to AI agents in advanced, integrated applications.

The latest product release lets customers embed AI in any interface to power their processes from within. Appian customers, including Acclaim Autism, Century Fire Protection, Hitachi, the Texas Department of Public Safety, and the University of South Florida, are seeing transformative outcomes from this process-first approach.

Acclaim Autism  treats children with Autism Spectrum Disorder. Their manual intake process left patients waiting up to six months for care. With Appian, they cut intake time by 83%. Acclaim Autism implemented Appian AI in just three weeks to extract diagnosis information from unstructured medical documents, ensuring accurate medical information is reflected to guarantee compliance and expedite the intake process. And because of Appian’s private AI approach, they remain compliant with HIPAA and other privacy standards. Now, they are delivering faster care to patients in need.

Century Fire Protection had a team of people manually processing over thousands of invoices and order acknowledgements, causing them to frequently miss early payment discounts. Appian’s Customer Success team built an accounts payable application that uses Appian AI to automatically classify documents and extract data. This new approach cut invoice processing time by 36% and reduced missed discounts by 50%.

As a multinational company with a diverse portfolio spanning digital systems, power, healthcare, and more, Hitachi recognized opportunities to optimize its internal processes. To further enhance data consolidation, cross-sell visibility, and the creation of compelling sales proposals, Hitachi partnered with Appian. Through this partnership, Hitachi ensures that their AI receives high-quality data while unifying systems, automating pipelines, and accelerating application development. The program is expected to achieve a 20% reduction in operating expenses, a 60% improvement in time-to-market, and increased sales productivity—modernizing sales operations through data informed by AI and process automation.

The Texas Department of Public Safety  deployed a generative AI chatbot to streamline its procurement process. The Appian chatbot taps into internal data to give procurement officials instant access to regulatory information and guidance on state contracting procedures. By putting comprehensive procurement data at the fingertips of over 10,000 stakeholders, Appian AI gives the Texas DPS the efficiency it needs to serve the community.

The University of South Florida (USF)  academic advisors use Appian AI to give students faster, more personalized support. Advisors query USF’s data fabric through a generative AI chatbot that answers questions about student cases and generates meeting agendas, action plans, and follow-up emails. Appian AI saves advisors time in preparing for each 30-minute meeting, so they get that time back to connect with students. USF deployed Appian in under two months to advisors serving up to 50,000 students a year.

“AI is most powerful when it’s embedded within processes, not operating in isolation,” said Randy Guard, Chief Marketing Officer, Appian. “Our customers are proving that embedding AI agents within processes optimizes operations, enhances accuracy, and accelerates outcomes—unlocking AI’s full potential in a governed, accountable way.”

Process is more powerful with AI and AI is more powerful in a process. Learn more about how Appian customers are putting AI to work and driving process transformation.

About Appian

Appian is The Process Company. We deliver a software platform that helps organizations run better processes that reduce costs, improve customer experiences, and gain a strategic edge. Committed to client success, we serve many of the world’s largest companies across industries. For more information, visit appian.com. [Nasdaq: APPN]

Follow Appian: LinkedIn, X (Twitter)

Photo – https://laotiantimes.com/wp-content/uploads/2025/04/appian_customers_unlock_ai_full_potential_by_embedding_it.jpg
Logo – https://laotiantimes.com/wp-content/uploads/2025/04/appian_400px_blank_logo-1.jpg

AIA Singapore celebrates SG60 with a year of initiatives to empower holistic well-being across the nation

Aligned to the theme of “Building Our Singapore Together”, the efforts aim to make a meaningful impact on Singaporeans of all generations


SINGAPORE – Media OutReach Newswire – 30 April 2025 – AIA Singapore today announced a year-long line-up of initiatives designed to connect with Singaporeans across all ages, empowering individuals to enhance their holistic wellness. Aligned with nationwide celebrations, these initiatives also emphasise giving back to the community, reinforcing AIA Singapore’s commitment to continue making a meaningful impact in Singapore and for its people.

These initiatives include:

  • Launching a customised “Live Better with AIA” Monopoly game set to empower individuals and families to embrace a holistic approach to life, focusing on physical, financial, and mental wellbeing.
  • Rolling out a family-centric campaign to encourage Singaporeans to strengthen and secure their family’s financial future.
  • Partnering with Rainforest Wild ASIA at the Mandai Wildlife Reserve to inspire a love for nature and wildlife amongst Singaporeans by encouraging meaningful connections that improve wellbeing.
  • Series of events specifically catered to affluent and High-Net-Worth (HNW) clients from the AIA Altitude programme, providing them with bespoke experiences that reflects our ‘Wealthbeing by AIA’ proposition.
  • Strengthening community bonds with Corporate Social Responsibility (CSR) activities focused on giving back to less-privileged members of society communities and making a positive social impact.

“AIA Singapore has proudly championed the health and well-being of Singaporeans across generations. As needs evolve, we remain committed to introducing innovative initiatives that promote holistic well-being and redefine what it means to live a healthy and active lifestyle. As Singapore marks its 60th birthday, we reaffirm our dedication to helping Singaporeans live Healthier, Longer, Better Lives,” said Irma Hadikusuma, Chief Marketing and Healthcare Officer of AIA Singapore.

Live Better with AIA x Monopoly
The “Live Better with AIA” Monopoly game set is Singapore’s first-ever insurer-customised edition of the iconic game. Designed to reflect the nation’s unique culture and experiences, it takes players through key life milestones and decisions, highlighting challenges and opportunities in health, wellness, financial planning, and social responsibility.

Some stand-out features of the “Live Better with AIA” Monopoly game set include:

  • Street tiles representing a Singaporean’s continuous journey of self-growth: Each tile represents distinct lifestyle enhancements, from essential needs to ultimate luxury. By integrating local cultural elements and unique Singaporean experiences, the tiles are designed to reflect the players’ diverse aspirations.
  • Traditional houses and hotels replaced with Upgrades and Transformations: Upgrade represents a significant milestone in enhancing one’s lifestyle, such as advanced workshops, personalised wellness plans, or high-end home features. Transformations signify even higher levels of achievement, like attaining expert certifications, investing in luxury property, or accessing exclusive experiences.
  • ‘Chance’ cards with a local flavour: Chance cards incorporate Singaporean slang while retaining their original outcomes. Players are encouraged to get up and move to earn their cash, promoting an active lifestyle.
  • ‘Community chest’ cards with relatable life moments and community engagement: Players can experience a range of real-life scenarios, such as earning bonuses, receiving angbao money at Chinese New Year, and celebrating family milestones like winning an award.

Irma said, “The Live Better with AIA Monopoly goes beyond financial planning. It’s a platform for families to bond over, learn together, and make informed decisions that enhance their holistic wellbeing. It’s not just about winning – it’s about building a life filled with purpose, personal growth, and meaningful connections.”

The “Live Better with AIA” Monopoly game set is exclusively available through AIA insurance representatives. More details can be found here: www.aia.com.sg/monopoly

AIA Better Together Promotion
To celebrate SG60 and the National Family Festival in June, AIA Singapore is launching a special campaign to help families safeguard their financial future. From 6 May to 31 July 2025, AIA Singapore is offering up to 20% off eligible plans plus a free family adventure pass to Mandai Wildlife Reserve (worth S$200).

This initiative aligns with the national focus on families, empowering Singaporeans—especially young families—to build a strong financial foundation for the future. It also reflects AIA Singapore’s commitment to supporting and strengthening families, recognising their vital role in shaping a resilient society. More details on tthe promotion can be found here from 6 May: www.aia.com.sg.

AIA Singapore’s tapir adoption and AIA Vitality bounce sponsorship at Rainforest Wild ASIA
In February this year, AIA Singapore celebrated the opening of Rainforest Wild ASIA at Mandai Wildlife Reserve, reinforcing its commitment to community engagement, wildlife conservation, and healthier lifestyles. As AIA Singapore continues to support initiatives that promote well-being and sustainability, this collaboration aligns with the AIA One Billion initiative, which aims to empower one billion people to live Healthier, Longer, Better Lives by 2030. For more details, please refer to the press release.

Elevating the ‘Wealthbeing by AIA’ Proposition for high-net-worth clients (HNW)
As part of AIA Singapore’s continued efforts to serve affluent and HNW clients in Singapore and across the region, a curated series of events, momentos and experiences catering specifically to AIA Altitude members will be held throughout the year. Members of the by-invite-only programme will be provided access to unique and bespoke opportunities that reflect the ‘Wealthbeing by AIA‘ proposition, our belief that true wealth transcends mere financial wellness and encompasses holistic wellness.

Additionally, AIA Altitude Pinnacle members celebrating their 60th birthday in 2025 will be gifted an exclusively designed Silk Scarf designed by local designer and founder of Singapore lifestyle brand Onlewo, Mike Tay[1]. The design on the scarf captures the dynamic blend of Singapore’s heritage and progressive nature. The exquisite design mirrors AIA Singapore’s commitment to evolve alongside customers as a trusted partner in health and wealth, a similar reflection Singapore’s transformation in the past six decades into a metropolitan city.

AIA Altitude will also be partnering with the Michelin Guide to present Gastronomic Heritage, a booklet featuring prominent four family-owned restaurants and chefs from Singapore, each with a rich legacy spanning multiple generation. Pulling parallels between these eateries and one’s wealth planning journey, Gastronomic Heritage will spotlight key values about legacy building and inheritance, spurring AIA Altitude members to curate conversations about growing and protecting their wealth holistically. They will also be treated to an experiential, specially curated dish or experience at these featured restaurants.

Other exclusive events for AIA Altitude members lined up for the year include wine and sake pairing sessions with featured brands from Gastronomic Heritage, exclusive SG60 National Day celebration at the AIA Wealth Centre overseeing the view of Padang, a trip to local Gin distillery Brass Lion, paired with a hands-on experience to craft an exclusive bottle of Gin infused with familiar local flavours, and more.

Beyond leisure and enjoyment, these events will also incorporate insightful business topics, ranging from investment strategies and legacy planning to wealth enhancement, empowering AIA Altitude members to achieve holistic success in both their personal and professional lives.

AIA strengthens community bonds through increased focus on CSR Initiatives
AIA Singapore is dedicating the year to giving back to the community through a series of CSR initiatives, with AIA staff and insurance representatives participating in volunteer programmes to support those in need. Its adopted charities will also be invited to share about their mission and needs at various AIA office locations, encouraging employees and AIA insurance representatives to contribute meaningfully. This year, we will also recognise and celebrate the efforts of “AIA Connecting Lives” volunteers who dedicate their time to serving the community.

Additionally, as part of AIA Singapore’s sponsorship of Mandai Rainforest Wild Asia, special edition tapir plushies will be available for sale with all proceeds going to the AIA Better Lives Fund.

“SG60 is not just a time for celebration but also a moment of reflection on our shared values and goals as Singaporeans. This year, as we embrace ‘Building Our Singapore Together,’ we recognise that each of us has a role to play in supporting one another and shaping a stronger, more resilient nation,” said Irma.


[1] Mike Tay was also featured among the top 50 Most Influential Singapore Designer in Singapore Tatler Homes, 2016. More information available at: https://saineofficial.wordpress.com/2020/12/23/founder-of-onlewo-mike-tay-on-telling-the-singapore-story-through-fabrics/#:~:text=Mike%20Tay%20is%20the%20founder,in%20Singapore%20Tatler%20Homes%2C%202016.

* AIA Better Together Promotion 2025 Terms & Conditions apply

Hashtag: #AIASingapore

The issuer is solely responsible for the content of this announcement.

About AIA

AIA Group Limited and its subsidiaries (collectively “AIA” or the “Group”) comprise the largest independent publicly listed pan-Asian life insurance group. It has a presence in 18 markets – wholly-owned branches and subsidiaries in Mainland China, Hong Kong SAR[1], Thailand, Singapore, Malaysia, Australia, Cambodia, Indonesia, Myanmar, New Zealand, the Philippines, South Korea, Sri Lanka, Taiwan (China), Vietnam, Brunei and Macau SAR[2], and a 49 per cent joint venture in India. In addition, AIA has a 24.99 per cent shareholding in China Post Life Insurance Co., Ltd.

The business that is now AIA was first established in Shanghai more than a century ago in 1919. It is a market leader in Asia (ex-Japan) based on life insurance premiums and holds leading positions across the majority of its markets. It had total assets of US$305 billion as of 31 December 2024.

AIA meets the long-term savings and protection needs of individuals by offering a range of products and services including life insurance, accident and health insurance and savings plans. The Group also provides employee benefits, credit life and pension services to corporate clients. Through an extensive network of agents, partners and employees across Asia, AIA serves the holders of more than 43 million individual policies and 16 million participating members of group insurance schemes.

AIA Group Limited is listed on the Main Board of The Stock Exchange of Hong Kong Limited under the stock codes “1299” for HKD counter and “81299” for RMB counter with American Depositary Receipts (Level 1) traded on the over-the-counter market under the ticker symbol “AAGIY”.


[1] Hong Kong SAR refers to the Hong Kong Special Administrative Region.
[2] Macau SAR refers to the Macau Special Administrative Region.

Goodme, China high-quality and cost-effective fresh fruit tea earns popularity among Japanese tourists

TOKYO, JAPAN – Media OutReach Newswire – 30 April 2025 – With the visa-free transit policy for Japanese tourists implemented by China at the end of 2024, as well as its high-quality yet low-cost consumption and geographical advantages, an increasing number of Japanese tourists have been attracted to China and it is integral part of their pleasure-seeking experience to eat, drink and be merry. Among them, healthy and delicious Chinese fresh fruit tea has become a must-have on the journey. As a Chinese freshly made tea beverage brand, Goodme has naturally become a classic try for Japanese tourists with its product strengths in quality-price performance and brand influence.

On April 18, the A+ Cheese Grape Fruit Tea, one of the classics offered by Goodme as a Chinese freshly made tea beverage brand made its return, with the cumulative sales exceeding 230 million cups. The tea beverage made of seasonal grapes costs only RMB 20 yuan, equivalent to about 388 yen, in China, while a cup of Summer Black grapevine fruit tea costs 1,150-1,250 yen in Japan, 3-4 times the price in China. This Chinese freshly made tea beverage brand has earned great popularity among domestic and overseas consumers with its excellent product strengths and market reputation.

It is the great value for the price and rich product variety that make the Chinese fresh fruit tea a classic delicacy. In the offline franchise stores of Goodme, a cup of grape-made fruit tea, pineapple-made fruit tea, or apple-made fruit tea costs 389 yen, while in Japan it costs 518-1250 yen, 2-3 times more than the price of similar products in China, let alone the lack of the apple-made fruit tea in Japan.

As China continues to relax its visa-free policies, the enthusiasm of Japanese tourists visiting China is soaring. It has become a phenomenal experience with the sense of ritual among them to try the Chinese fresh fruit tea. Goodme is not only popular in China but also well loved by more and more Japanese tourists nowadays. “Day day good me day day good” has gradually become a prevailing fashion trend among the younger generation at home and abroad.

As of now, Goodme has opened more than 10,000 stores as the only freshly made beverage brand in the world with more than 10,000 stores to adopt fresh ingredients. As it was listed in Hong Kong this February, Goodme has formulated a strategic plan to expand overseas markets.

Hashtag: #Goodme

The issuer is solely responsible for the content of this announcement.

About Goodme

Goodme is one of China’s freshly made tea beverage brands, with the highest annual sales of nearly 1.2 billion cups in 2023. It is known for high-quality ingredients with a short shelf life for freshly made beverage delivered by its cold chain logistics, featuring the freshness in every cup that “you can have every day and never get tired of”. It was listed in Hong Kong, China in February 2025 (stock code: 01364).

Appian Embeds Agentic AI into Business Processes to Deliver Scalable, Governable Enterprise Value

Introducing new AI features and Data Fabric enhancements to deliver real-time insights and measurable impact.

SYDNEY, April 30, 2025 /PRNewswire/ — Appian (NASDAQ: APPN) today announced agentic AI platform enhancements to help organisations build, deploy, and scale intelligent process applications. As the Process Company, the Appian Platform provides AI-powered solutions to orchestrate and transform critical business processes. This release introduces the beta launch of Agent Studio and the general availability of AI Document Center. Additional enhancements include expanded data fabric support for document management and semantic search across data and documents.

Appian Embeds Agentic AI into Business Processes to Deliver Scalable, Governable Enterprise Value
Appian Embeds Agentic AI into Business Processes to Deliver Scalable, Governable Enterprise Value

Agentic AI makes business processes smarter and faster

Appian has embedded AI digital workers operating in process for years. Now with Agent Studio, Appian AI agents are more powerful and governable than ever. Agent Studio enables users to design and deploy AI agents with greater autonomy and contextual awareness. These AI agents can reason through complex, multi-step tasks. They can also interact with multiple systems to update records, send emails, and respond dynamically to new inputs. Agent Studio allows developers to create intelligent agents that not only execute actions but also make informed decisions based on real-time data and business logic.

Users can quickly and easily create agents for document processing with AI Document Center — an all-in-one application for enterprise-grade IDP. AI Document Center is designed to handle complex document formats with high extraction accuracy and scalability for enterprise workloads. Appian customer, Century Fire Protection, used AI Document Center to automate their accounts payable with AI, reducing invoice operating time by 36%.

“Adding Appian AI into Century’s AP management workflow has resulted in a more modern, controlled and efficient process, leading to significant benefits,” said Alex Polyakman, CFO of Century Fire Protection.

Smart search leverages AI-driven semantic search to enhance record retrieval. Smart search allows you to search across your entire data fabric, including text fields or documents attached to a record—all at enterprise scale. Smart search goes beyond keyword matching by interpreting intent, uncovering connections, detecting patterns, and surfacing related records.

In addition to high-availability, generative AI Agents can now be used in autoscale processes, helping enterprises stay responsive and efficient even when demand increases. Autoscale is an Appian Cloud capability that dynamically adjusts process execution capacity based on demand. Specifically designed for high-volume, high-throughput automation, process autoscale delivers 10-100x the power without over-provisioning resources. Now, organisations can power their high-volume, high-value generative AI use cases with enterprise-grade AI.

Other platform enhancements to data fabric and total experience include:

  • Data fabric now includes native support for documents. Organisations can manage, relate, and secure documents using record types, eliminating the need for folder-based organisation and allowing developers to create more document-centric applications.
  • Incremental syncs support dynamic data environments. Data fabric now supports external data sync as frequently as every 15 minutes and up to 20 million rows per record to ensure current, responsive applications.
  • Form headers and wizards accelerate beautiful form design. Appian UIs now automatically incorporate common form header, wizard functionality, and recommend modern UX patterns. Forms generated from data fabric will see the most improvements.

“AI works best in a process. Appian’s process orchestration and data fabric provide the foundation needed to get real value out of AI while maintaining data security,” said Michael Beckley, CTO and Founder, Appian.

Appian is the Process Company, focused on improving processes that define a business—from how it operates to how it serves customers and delivers value. By integrating AI into processes, Appian gives AI purpose, governance, and accountability—all essential to delivering its value. Learn how AI can be part of your processes.

About Appian

Appian is The Process Company. We deliver a software platform that helps organisations run better processes that reduce costs, improve customer experiences, and gain a strategic edge. Committed to client success, we serve many of the world’s largest companies across industries. For more information, visit appian.com. [Nasdaq: APPN]

Follow Appian: LinkedIn, X (Twitter)

Photo – https://laotiantimes.com/wp-content/uploads/2025/04/appian_agentic_ai.jpg
Logo – https://laotiantimes.com/wp-content/uploads/2025/04/appian_400px_blank_logo.jpg

Innovent Announces First Patient Dosed in Phase 1 Study of IBI3020, Global First-in-class Dual Payload CEACAM5 ADC, in Patients with Advanced Malignancies

SAN FRANCISCO and SUZHOU, China, April 30, 2025 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and other major diseases, announced completion of the first patient dosing for IBI3020, its first-in-class dual-payload CEACAM5 ADC, in Phase 1 clinical trial for the treatment of patients with advanced solid tumors. IBI3020 is the first dual-payload ADC developed from Innovent’s proprietary DuetTx® dual-payload ADC platform and the first dual-payload ADC globally known in the same class to complete the first-in-human dosing.

The study is an open-label, multi-regional Phase 1 study evaluating the safety, tolerability, and preliminary efficacy of IBI3020 in participants with advanced solid tumors, as well as determining the recommended Phase 2 dose (RP2D). The study has received IND approval in the U.S. recently and will be conducted in both China and the U.S.

As a global first-in-class ADC candidate, IBI3020 is generated from Innovent’s proprietary DuetTx® dual-payload ADC platform. The internationalization of the CEACAM5-dependent ADC occurs after IBI3020 selectively binds to CEACAM5-expressing tumor cells, followed by lysosomal degradation. This process releases two types of cytotoxic payloads, leading to cell killing of tumor cells.

In preclinical studies, IBI3020 has demonstrated robust antitumor activity across various tumor-bearing pharmacology models, with a notable bystander killing effect. Additionally, IBI3020 has shown favorable safety characteristics in preclinical models, with an overall manageable safety profile.

Professor Yu Jinming, Shandong Cancer Hospital, stated:” Carcinoembryonic antigen (CEA), also known as CEACAM5, is a glycosylphosphatidylinositol-anchored cell-surface glycoprotein involved in cell adhesion, invasion, and metastasis of cancer cells. There is a significant clinical need for effective therapies in advanced colorectal cancer, non-squamous lung cancer, gastric cancer, pancreatic cancer, and others. CEACAM5 is overexpressed in these solid tumors but shows limited expression in healthy tissues, making it a potentially safe and promising therapeutic target. The dual payload of IBI3020 consists of two types of payloads that have been clinically validated. This dual-payload design has demonstrated enhanced tumor-killing effects in preclinical studies. We look forward to observing the clinical profiles and potential breakthrough of IBI3020 in terms of safety, tolerability, and efficacy in clinical trials.”

Dr. Hui Zhou, Senior Vice President of Innovent, stated: “We are pleased to announce the successful dosing of the first patient dose with IBI3020. We will continue to advance the global development of IBI3020, aiming to offer better treatment options for patients with advanced solid tumors. Innovent possesses innovative ADC technology platforms with independent intellectual property rights. Multiple ADC molecules have clinically validated their differentiated competitiveness. IBI3020, Innovent’s first dual-payload ADC, has successfully entered clinical trials and is the first dual-payload ADC globally known in the same class to complete the first-in-human dosing, marking a breakthrough in Innovent’s ADC technology. We will continue our “IO+ADC” strategy, focusing on next-generation innovations with global potential to benefit cancer patients worldwide.”

About IBI3020

IBI3020 is a global first-in-class ADC candidate developed from Innovent’s proprietary DuetTx® dual-payload ADC platform. The CEACAM5 dependent ADC internalization occurs after IBI3020 selectively binds to the CEACAM5-expressing tumor cells, followed by the lysosomal degradation. This process releases two types of cytotoxic payloads, leading to tumor cell killing.

The multi-regional Phase 1 study of IBI3020, initiated in China, assesses the safety, tolerability, and preliminary efficacy of IBI3020 in patients with advanced solid tumors and aims to determine the recommended Phase 2 dose (RP2D). The study has also received IND approval in the U.S. recently and will be conducted in China and the U.S.

About Innovent

Innovent is a leading biopharmaceutical company founded in 2011 with the mission to empower patients worldwide with affordable, high-quality biopharmaceuticals. The company discovers, develops, manufactures and commercializes innovative medicines that target some of the most intractable diseases. Its pioneering therapies treat cancer, cardiovascular and metabolic, autoimmune and eye diseases. Innovent has launched 15 products in the market. It has 3 new drug applications under regulatory review, 3 assets in Phase III or pivotal clinical trials and 16 more molecules in early clinical stage. Innovent partners with over 30 global healthcare companies, including Eli Lilly, Sanofi, Incyte, Adimab, LG Chem and MD Anderson Cancer Center.

Guided by the motto, “Start with Integrity, Succeed through Action,” Innovent maintains the highest standard of industry practices and works collaboratively to advance the biopharmaceutical industry so that first-rate pharmaceutical drugs can become widely accessible. For more information, visit www.innoventbio.com, or follow Innovent on Facebook and LinkedIn.

Statement: (1) Innovent does not recommend the use of any unapproved drug (s)/indication (s).

( 2) Ramucirumab (Cyramza) and Selpercatinib (Retsevmo) and Pirtobrutinib (Jaypirca) were developed by Eli Lilly and Company.

Forward-Looking Statements

This news release may contain certain forward-looking statements that are, by their nature, subject to significant risks and uncertainties. The words “anticipate”, “believe”, “estimate”, “expect”, “intend” and similar expressions, as they relate to Innovent, are intended to identify certain of such forward-looking statements. Innovent does not intend to update these forward-looking statements regularly.

These forward-looking statements are based on the existing beliefs, assumptions, expectations, estimates, projections and understandings of the management of Innovent with respect to future events at the time these statements are made. These statements are not a guarantee of future developments and are subject to risks, uncertainties and other factors, some of which are beyond Innovent’s control and are difficult to predict. Consequently, actual results may differ materially from information contained in the forward-looking statements as a result of future changes or developments in our business, Innovent’s competitive environment and political, economic, legal and social conditions.

Innovent, the Directors and the employees of Innovent assume (a) no obligation to correct or update the forward-looking statements contained in this site; and (b) no liability in the event that any of the forward-looking statements does not materialize or turn out to be incorrect.

137th Canton Fair Phase 2 Highlights Quality Home Life Through Innovation and Green Thinking

GUANGZHOU, China, April 30, 2025 /PRNewswire/ — Phase 2 of the 137th China Import and Export Fair (Canton Fair), taking place from April 23 to 27, spans an impressive 515,000 square meters of exhibition space. With 10,313 participating companies, 273 more than the previous session, this phase centers on quality home life.

In every household, the kitchen stands as a cornerstone of comfort and function. Yet even small daily challenges, like managing kitchen waste, can disrupt the rhythm of home life. That’s why even a simple product like a trash bin has become a beacon of innovation, with exhibitors at the Fair showcasing diverse solutions that cater to real consumer needs.

One standout comes from EKO Group Ltd., which exhibited a semi-round smart sensor bin that exemplifies the fusion of design and technology. This model features motion-activated, hands-free operation, a silent-closing lid, a removable inner bucket for easy cleaning, and a fingerprint-resistant stainless-steel body. Its sleek design reflects a growing consumer desire for functional products that elevate both hygiene and style in everyday spaces.

While some companies are enhancing waste management to improve the quality of home life, others are reimagining waste itself to elevate the essence of quality living. Intco Recycling Resources Co., Ltd., a high-tech manufacturer specializing in renewable resource recycling, is pioneering the transformation of recycled plastics into elegant, high-quality home décor. At their booth, buyers found photo frames, mirrors, table accessories, and other decorative items, all crafted entirely from recycled materials. These products not only reduce environmental impact but also prove that sustainability and sophisticated design can coexist.

The response from international buyers was enthusiastic. Du Mingze, Marketing Manager at Intco Recycling, noted that most inquiries on the first day came from European and Central Asian markets, reflecting a growing global appetite for eco-conscious living solutions.

From intelligent waste bins to recycled home items, Chinese companies at the Canton Fair are showing the world how innovation and environmental consciousness can go hand in hand. As the global demand for innovative and sustainable home products continues to grow, the Canton Fair demonstrates a powerful vision: a future where everyday living is elevated through design, enabled by technology, and sustained by green thinking.